WorldHeart
This article was originally published in The Gray Sheet
Executive Summary
Enhanced version of ePTFE inflow conduit for use with the Novacor LVAS left ventricular assist system is reintroduced in EU countries following European approval, the firm announces April 10. WorldHeart withdrew the product in September 2001 to enhance structural integrity following reports of kinking in recovered devices. WorldHeart also has received go-ahead to recommence its halted NICE study of the conduit in the U.S. and plans to seek FDA approval later this year...
You may also be interested in...
WorldHeart/Edwards Pump Up Novacor As Destination Therapy In Europe
WorldHeart and marketing partner Edwards Lifesciences will promote the Novacor left ventricular assist device (LVAD) as a destination therapy for heart failure patients in Europe following CE mark approval of a package of device enhancements, expected by the end of May
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.